Standard BioTools
LAB
83 hedge funds and large institutions have $196M invested in Standard BioTools in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 25 closing their positions.
92.38% more ownership
Funds ownership: 0% → 92.38% (+92%)
7% more capital invested
Capital invested by funds: $182M → $196M (+$13.3M)
4% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 27
15% less funds holding
Funds holding: 98 → 83 (-15)
43% less call options, than puts
Call options by funds: $74K | Put options by funds: $130K
56% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 25
Top Buyers
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$15.9M |
| 2 |
Millennium Management
New York
|
-$2.38M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$2.31M |
| 4 |
Lazard Asset Management
New York
|
-$2.26M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.84M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$8K | -1,000 | Closed |
|
|
SIM
102
Sonora Investment Management
Tucson,
Arizona
| – | -$4K | -500 | Closed |
|
103
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$3K | -396 | Closed |
|
|
PIA
104
Piedmont Investment Advisors
Durham,
North Carolina
| – | -$1.49K | -186 | Closed |
|
|
CSS
105
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$1K | -123 | Closed |
|
|
QI
106
QS Investors
New York
| – | -$1K | -41 | Closed |
|
LAB Hedge Fund Activity: Q4 2016 in Review
83 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2016, worth a combined $196M — up 7.3% from $182M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of LAB and 11 opened new positions — a net loss of 14 holders — while 27 trimmed existing stakes and 26 added.
The largest buyer was Levin Capital Strategies, adding an estimated $8.61M. The largest seller was Franklin Resources, exiting entirely with an estimated $15.9M sold.
- 83 institutional investors held Standard BioTools (LAB) as of Q4 2016, down from 98 in Q3 2016.
- Funds reported $196M of Standard BioTools stock for Q4 2016, up 7.3% quarter-over-quarter.
- 11 funds opened new Standard BioTools positions in Q4 2016 and 25 closed out, a net change of -14 holders.
- The largest Standard BioTools buyer in Q4 2016 was Levin Capital Strategies, an estimated $8.61M added.
- The largest Standard BioTools seller in Q4 2016 was Franklin Resources, an estimated $15.9M sold.
Based on aggregated 13F filings for Q4 2016.